Skip to main content

Table 3 Long-term effect of exercise on fatigue and physical activity among breast cancer patients only

From: Four-year effects of exercise on fatigue and physical activity in patients with cancer

 

Baseline

Baseline to 4 years post-intervention

 

Within-group differences

Between-group differences

Mean

SD

Mean [95% CI]

Mean [95% CI]

Effect size

Multidimensional Fatigue Inventory (MFI)

 General fatigue

I

9.28

6.08

0.13 [−1.11, 1.38]

−0.26 [− 1.65, 1.12]

0.04

UC

10.01

6.11

−0.48 [−1.78, 0.82]

Reference

 

 Physical fatigue

I

9.05

6.32

−0.53 [−1.83, 0.76]

−1.05 [−2.53, 0.43]

0.17

UC

10.01

6.35

−0.33 [−1.68, 1.02]

Reference

 

 Mental fatigue

I

9.32

6.64

0.05 [−1.24, 1.33]

−0.09 [− 1.59, 1.41]

0.01

UC

9.77

6.68

−0.28 [−1.62, 1.06]

Reference

 

 Reduced activity

I

7.04

5.07

−0.21 [−1.21, 0.79]

0.17 [−1.02, 1.36]

0.03

UC

7.62

5.09

−0.95 [−1.98, 0.09]

Reference

 

 Reduced motivation

I

7.92

6.42

0.51 [−0.73, 1.74]

−0.20 [−1.27, 0.87]

0.03

UC

8.42

6.71

0.39 [−0.91, 1.70]

Reference

 

Short Questionnaire to Assess Health-enhancing physical activity (SQUASH)

 Total physical activity

I

UC

640.55

750.38

794.85

792.05

36.76 [− 125.46, 198.98]

− 167.21 [− 336.75, 2.32]

117.70 [−40.61, 276.02]

Reference

0.15

 Sport and leisure physical activity

I

UC

211.59

217.57

332.60

332.04

93.91 [32.33, 155.49]*

56.71 [−8.03, 121.45]

33.66 [−40.26, 107.57]

Reference

0.10

  1. I exercise intervention group, UC usual care group, SD standard deviation, CI confidence interval
  2. *Statistically significant (p < 0.05)
  3. Between-group effects were assessed using mixed models including the measurements obtained at 18 and 36 weeks and 4 years, adjusted for tumor receptor status and the value of the outcome variable at baseline as well as for stratification factors: age, radiotherapy, hospital, and tissue expander. Within-group effects were assessed using mixed models including the measurements obtained at baseline, 18 and 36 weeks, and 4 years, adjusted for tumor receptor status as well as for stratification factors: age, radiotherapy, hospital, and tissue expander
  4. Baseline results and within-group differences were based on participants having baseline measurements. Between-group differences were based on participants having measurements at 18 weeks, 36 weeks, or 4 years